Although there are no publicly available small compound inhibitors of TRIT1 enzymatic activity, arsenic trioxide, through its direct effects on selenium-containing proteins [36,38], is potentially effective in small-cell lung cancer cells with high levels of TRIT1. Here, TRIT1 is linked to small cell lung carcinoma.